RxDoctor Payments Data

Julia Witte

Nurse Practitioner · Grand Rapids, MINPI 1053960807

Payments from drug & device makers

$2,197in general payments, 2019–2025

Across 115 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$357
  • AbbVie$244
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$183
  • Teva Pharmaceuticals USA, Inc.$175
  • Novo Nordisk$129
  • Edwards Lifesciences$125
  • plus $984 from 26 others

What the payments were for

  • Food & beverage$2,09795%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,197 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol115$12,145
VeozahFezolinetant15$7,665
Estradiol (Twice Weekly)Estradiol43$4,964
DottiEstradiol11$1,442
ProgesteroneProgesterone, Micronized11$555
Medroxyprogesterone Acetate13$553
Clobetasol Propionate36$539
Oxybutynin Chloride19$263
Metronidazole16$234
Fluconazole11$67
Clonidine Hcl14$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncVeozah$357$7,66515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →